| Date | Form | Description | Docs | XBRL | Pages |
| 05/02/22 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 04/27/22 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 04/22/22 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 04/21/22 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 04/15/22 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 04/15/22 | 8-K | Current report filing |
|
|
2 |
| 03/11/22 | 8-K | Current report filing |
|
|
13 |
| 03/11/22 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 03/11/22 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 03/11/22 | 4 | Statement of changes in beneficial ownership of securities |
|
2 |
Latest News & Events
Anixa Biosciences Announces Dr. Jose Conejo-Garcia will Keynote the South Carolina Clinical & Translational Research Institute 2026 Retreat
Read More...Anixa Biosciences Reports Encouraging Patient Survival Observations in Ovarian Cancer CAR-T Trial; Achieves Regulatory Approval Enabling Major Dose Escalation
Read More...Anixa Biosciences Secures United States Adopted Names Council Approval of Non-Proprietary Name for its CAR-T Therapy, a Key Step Toward Future Commercialization
Read More...